For people with diabetes a lack of insulin means regulating the body's blood sugar levels is a challenge. As the prevalence of the disease continues, reversing the trend is a focus for Novo Nordisk.
High throughput screening (HTS) has been the leading paradigm of small molecule drug discovery for the biopharmaceutical industry throughout the last 2 decades.
In drug discovery, the trend continues to move away from target centric biochemical assays towards more phenotypic and “genomic” approaches to understanding a disease and finding ways to address it.
By Dr Berwyn Clarke, Chief Scientific and Development Officer at Lab21 Limited
Most major clinical trials today utilize electronic data capture (EDC) systems, which are configured to handle the specific requirements of a trial’s protocol and provide clinical sites with a computerized system for data entry.